Shares of ViroPharma (VPHM +7.2%) spike midday after rumors surface that the company could be an...
Shares of ViroPharma (VPHM +7.2%) spike midday after rumors surface that the company could be an acquisition target. While "no deal is imminent," potential buyers have expressed "preliminary interest," according to three anonymous sources cited by Reuters. The company has declined to comment. BioMarin (BMRN -0.2%) is also mentioned although the company says it is "not actively looking to be acquired."
From other sites
at Investor's Business Daily (Feb 12, 2015)
at Investor's Business Daily (Jan 26, 2015)
at CNBC.com (Jan 16, 2015)
at CNBC.com (Jan 15, 2015)
at Benzinga.com (Jan 15, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs